AbbVie Inc. et al v. Dr. Reddys Laboratories, Ltd. et al
| Genentech, Inc. and AbbVie Inc. |
| Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. |
| 1:2020cv00968 |
| July 21, 2020 |
| U.S. District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 18, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 STIPULATION Plaintiffs to file First Amended Complaint by AbbVie Inc., Genentech, Inc.. (Attachments: #1 First Amended Complaint, #2 Red Line Comparison, #3 Exhibit A, #4 Exhibit B, #5 Exhibit C, #6 Exhibit D)(Taylor, James) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner and Beth Finkelstein filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. Signed by Judge Leonard P. Stark on 9/10/20. (ntl)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Constance S. Huttner and Beth Finkelstein - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Pro Hac Vice Attorney Ashley N. Mays-Williams for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01009-LPS, 1:20-cv-00968-LPS(kmd) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddys Laboratories, Inc. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
| Filing 9 ANSWER to #1 Complaint, and Separate Defenses by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Ormerod, Eve) |
| Filing 8 AFFIDAVIT of Service for Complaint served on Andrew J. Miller, Esq. on July 24, 2020, filed by AbbVie Inc., Genentech, Inc.. (Attachments: #1 Exhibit A & B)(Taylor, James) |
| Pro Hac Vice Attorneys Chad J. Peterman, Eric W. Dittmann, Bruce M. Wexler for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Pro Hac Vice Attorneys Katherine A. Daniel and Krystina Ho for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Pro Hac Vice Attorney Eric W. Dittmann for AbbVie Inc. and Genentech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Chad Peterman, Eric Dittmann, Bruce Wexler, Ashley Mays-Williams, Katherine Daniel and Krystina Ho filed by Genentech, Inc., AbbVie Inc. Signed by Judge Leonard P. Stark on 7/30/20. (ntl)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Chad Peterman, Eric Dittmann, Bruce Wexler, Ashley Mays-Williams, Katherine Daniel and Krystina Ho - filed by AbbVie Inc., Genentech, Inc.. (Taylor, James) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 6 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 8, 2020. Date of Expiration of Patent: 06/27/2031; 01/29/2032; 05/26/2030.Thirty Month Stay Deadline: 10/11/2023. (Taylor, James) |
| Remark: Civil Cover Sheet updated per counsel's request. (kmd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc.. (Taylor, James) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (Taylor, James) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,546,399 ;9,174,982 ;8,722,657. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3076240.) - filed by AbbVie Inc., Genentech, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(mal) (Attachment 4 replaced on 7/28/2020) (kmd). |
| No Summons Issued. (mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
